Medical/Healthcare News

Savara Inc. Launches aPAP ClearPathâ„¢, a Ground-breaking Blood Test for Rare Lung Disease

LANGHORN, PA — Savara Inc. (Nasdaq: SVRA) announced the recent launch of aPAP ClearPathâ„¢, a revolutionary serum-based blood test designed to provide definitive diagnoses of autoimmune Pulmonary Alveolar Proteinosis (aPAP), …

Savara Inc. Launches aPAP ClearPathâ„¢, a Ground-breaking Blood Test for Rare Lung Disease Read More